Combining Ellagic Acid with Bevacizumab Mediates the Cadherin Switch and Angiogenesis in a Glioblastoma Model

Abstract

OBJECTIVE: To observe the combining effect of ellagic acid (EA) with bevacizumab (BEV) on cadherin switch and angiogenesis of C6-glioma cell line